Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yeeeeeeeeesssssssssssssss
In Stuttgart Germany this morning a bit of pull back (Normal) but is starting to go back up again
CBIS $$$$$$ or £££££ or @@@@@@
Quote
"I think the shorts will come"
What kind of Shorts?
dressy, casual, denim, swim or Bermuda!! HA Ha Ha
CBIS ££££££ or €€€€€€€ or $$$$$$$$$
CANNABIS SCIENCE ORD (CXN) Stuttgart Markt Germany
Up 8.65%
EUR: 0.113 = USD 0.121
GO CBIS €€€€€€€€ or ££££££££ or $$$$$$$$$
Quote:"Decreasing Wealth!!!"
WRONG
I am buying and accumulating für the future when £££££SVFC££££ starts rolling.
GO £££££SVFC££££ $$$$$$SVFC$$$$$$ ££££££SVFC£££££
Quote:
"with logically indisputable data that I will be more than willing to let the investing public decipher for themselves"
Investing public can read and make his own mind up.
£££££SVFC£££££
Quote:
I was going to let BS continue this Weekend!!
Only BS post in here is ......
Novartis Spends $125 Million To Buy Chinese Vaccines Maker
ZURICH -(Dow Jones)- Swiss drugmaker Novartis AG (NVS) said Wednesday it plans to buy a majority stake in privately-held Chinese vaccines maker Zhejiang Tianyuan for around $125 million, to boost its presence in the world's third-largest vaccines market.
Does it mean for us $$$ Because Mellow Hope is the exclusive agent of Zhejiang
Tianyuan Bio-pharmaceutical Co., Ltd for International marketing and sales, and HTDS is the parent company of Mellow hope?!?!?!
Any ideas?
http://www.swissquote.ch/index/index_ser...
and
http://www.reuters.com/article/pressRele...
GLTA
And here comes Adam once again....
WHO CARES!!! I don't even bother to read the S**T he writes.
STRONG LONG
GO CTIC
I found this link on yahoo.
Very interesting.
http://www.nvestorz.com/blog/view/id_10/title_A-Theory-Behind-FDA-Approval-Delays/
GLTA
Okay thanks.
GLTA
FORM 4:
http://finance.aol.com/company/hemispherx-biopharma-inc/heb/ase/4/09918690/html/sec-filings
Is this good or bad?
I do not understand what the G means.
GLTA
Has someone seen this
http://finance.aol.com/company/hemispherx-biopharma-inc/heb/ase/3/09903242/html/sec-filings
Please explain good or bad.
GLTA
Thanks
Posted on the CTIC board (Yahoo) but is also in reference to HEB...
Wouldn't want to be Jim or Adam on Monday 6-Jun-09 02:43 pm A letter posted on the web as early as Monday pre-market with copies sent to all major news networks worldwide in which investors will be taking on the SEC, FTC and the Office of the President challenging them to reply. It will cover possible stock manipulation and back door disbursement of profits, specific to recent activity of The Street.com and its contributors, namely Adam Feuerstein who was instrumental in using public media and the internet to transmit false reports on several Bio stocks. It should be known that price drop and hedge fund purchases mysteriously coincided with the drops and immediately followed the post articles on The Street.com website. Specific to the demand for a public reply is as follows: Why did monitoring agencies question the CEO of Hemispherx Bio (HEB) about the sudden rise in stock price 8 days ago, while when the stock experienced a loss at greater than that rise rate, did not question the "reporter" at The Street.com as to their involvement in possible short selling, hedge fund involvement and price manipulation. Ironically Jim Cramer has recently begun a formal "short selling" petition that he publicly touted on his Mad Money CNBC show. Is this a ploy to mask his own activity and those of his financial circles to hide behind? ( see video for reference
Posted on the CTIC Yahoo board
Wouldn't want to be Jim or Adam on Monday 6-Jun-09 02:43 pm A letter posted on the web as early as Monday pre-market with copies sent to all major news networks worldwide in which investors will be taking on the SEC, FTC and the Office of the President challenging them to reply. It will cover possible stock manipulation and back door disbursement of profits, specific to recent activity of The Street.com and its contributors, namely Adam Feuerstein who was instrumental in using public media and the internet to transmit false reports on several Bio stocks. It should be known that price drop and hedge fund purchases mysteriously coincided with the drops and immediately followed the post articles on The Street.com website. Specific to the demand for a public reply is as follows: Why did monitoring agencies question the CEO of Hemispherx Bio (HEB) about the sudden rise in stock price 8 days ago, while when the stock experienced a loss at greater than that rise rate, did not question the "reporter" at The Street.com as to their involvement in possible short selling, hedge fund involvement and price manipulation. Ironically Jim Cramer has recently begun a formal "short selling" petition that he publicly touted on his Mad Money CNBC show. Is this a ploy to mask his own activity and those of his financial circles to hide behind? ( see video for reference
I also copied this from another board:
Read it , it is very intresting.
http://www.drpodell.org/ampligen.shtml
Dear patients:
We were very pleased that our four years of research trials on Ampligen for Chronic Fatigue Syndrome turned out to be successful. The press release below summarizes the results--that Ampligen was more effective than placebo for improving the exercise capacity among people with severe CFS. Ampligen is not yet on the market, and given the pace at which the FDA usually proceeds, it's fairly likely that approval and market availability are still far off in the future. However, Ampligen is available for persons with CFS who meet certain criteria under a special research program approved by the FDA. Unfortunately, this program is expensive, as participants have to pay not only for the drug and the intravenous administrations (twice weekly), but also for the costs of the research filings. nsurance reimbursement is not likely. Still, we have treated patients within this program, and plan to continue to do so as long as it's available. If you are interested, please contact our director of research Edwina (Wendy) King, PhD, APRN at 908 273-7770.
Richard N. Podell, M.D.
GLTA
Forget Adam.
We are going to sky-rocket.
Read:
http://www.rttnews.com/ArticleView.aspx?Id=968824&Category=Breaking%20News
GLTA
and a man from Switzerland!!!
GLTA